MediWound (MDWD) Tops Q1 EPS by 5c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
MediWound Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 20, 2020 7:01 AM EDTEscharEx U.S. Phase 2 Study Resumed Patient Screening
YAVNE, Israel, May 20, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (the Company), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced financial results for the first quarter ended March 31, 2020 and provided business and financial updates related to the COVID-19 pandemic.Â
First Quarter Business and Financial Highlights:
Total revenues for the first quarter of 2020 were $4.4 million Operating loss for the first quarter of 2020 was... More



